Department of Obstetrics and Gynaecology, The University of Hong Kong, Pokfulam, Hong Kong.
Department of Obstetrics and Gynaecology, University of the Philippines, Philippine General Hospital, Manila, Philippines.
J Obstet Gynaecol Res. 2021 May;47(5):1643-1650. doi: 10.1111/jog.14579. Epub 2021 Mar 1.
Since the outbreak of COVID-19, there have already been over 26 million people being infected and it is expected that the pandemic will not end in near future. Not only the daily activities and lifestyles of individuals have been affected, the medical practice has also been modified to cope with this emergency catastrophe. In particular, the cancer services have faced an unprecedented challenge. While the services may have been cut by the national authorities or hospitals due to shortage of manpower and resources, the medical need of cancer patients has increased. Cancer patients who are receiving active treatment may develop various kinds of complications especially immunosuppression from chemotherapy, and they and their carers will need additional protection against COVID-19. Besides, there is also evidence that cancer patients are more prone to deteriorate from COVID-19 if they contract the viral infection. Therefore, it is crucial to establish guidelines so that healthcare providers can triage their resources to take care of the most needed patients, reduce less important hospitalization and visit, and to avoid potential complications from treatment. The Asia and Oceania Federation of Obstetrics and Gynecology (AOFOG) hereby issued this opinion statement on the management of gynecological cancer patients during the COVID-19.
自 COVID-19 爆发以来，已有超过 2600 万人感染，预计疫情近期不会结束。不仅个人的日常活动和生活方式受到影响，医疗实践也进行了调整以应对这一紧急灾难。特别是癌症服务面临前所未有的挑战。由于人力和资源短缺，国家当局或医院可能已经削减了这些服务，而癌症患者的医疗需求却增加了。正在接受积极治疗的癌症患者可能会出现各种并发症，特别是化疗引起的免疫抑制，他们和他们的照顾者将需要额外的 COVID-19 保护。此外，有证据表明，如果癌症患者感染病毒，他们从 COVID-19 恶化的风险更高。因此，制定指南至关重要，以便医疗保健提供者能够对其资源进行分类，以照顾最需要的患者，减少不重要的住院和就诊，并避免治疗的潜在并发症。亚洲和大洋洲妇产科联合会（AOFOG）就此发布了关于 COVID-19 期间妇科癌症患者管理的意见声明。
